C

Chiome Bioscience Inc
TSE:4583

Watchlist Manager
Chiome Bioscience Inc
TSE:4583
Watchlist
Price: 180 JPY 20% Market Closed
Market Cap: 11.2B JPY
Have any thoughts about
Chiome Bioscience Inc?
Write Note

Intrinsic Value

The intrinsic value of one Chiome Bioscience Inc stock under the Base Case scenario is 26.71 JPY. Compared to the current market price of 180 JPY, Chiome Bioscience Inc is Overvalued by 85%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
26.71 JPY
Overvaluation 85%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Chiome Bioscience Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Chiome Bioscience Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Chiome Bioscience Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Chiome Bioscience Inc

Provide an overview of the primary business activities
of Chiome Bioscience Inc.

What unique competitive advantages
does Chiome Bioscience Inc hold over its rivals?

What risks and challenges
does Chiome Bioscience Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chiome Bioscience Inc.

Provide P/S
for Chiome Bioscience Inc.

Provide P/E
for Chiome Bioscience Inc.

Provide P/OCF
for Chiome Bioscience Inc.

Provide P/FCFE
for Chiome Bioscience Inc.

Provide P/B
for Chiome Bioscience Inc.

Provide EV/S
for Chiome Bioscience Inc.

Provide EV/GP
for Chiome Bioscience Inc.

Provide EV/EBITDA
for Chiome Bioscience Inc.

Provide EV/EBIT
for Chiome Bioscience Inc.

Provide EV/OCF
for Chiome Bioscience Inc.

Provide EV/FCFF
for Chiome Bioscience Inc.

Provide EV/IC
for Chiome Bioscience Inc.

What are the Revenue projections
for Chiome Bioscience Inc?

How accurate were the past Revenue estimates
for Chiome Bioscience Inc?

What are the Net Income projections
for Chiome Bioscience Inc?

How accurate were the past Net Income estimates
for Chiome Bioscience Inc?

What are the EPS projections
for Chiome Bioscience Inc?

How accurate were the past EPS estimates
for Chiome Bioscience Inc?

What are the EBIT projections
for Chiome Bioscience Inc?

How accurate were the past EBIT estimates
for Chiome Bioscience Inc?

Compare the revenue forecasts
for Chiome Bioscience Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chiome Bioscience Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chiome Bioscience Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chiome Bioscience Inc compared to its peers.

Compare the P/E ratios
of Chiome Bioscience Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Chiome Bioscience Inc with its peers.

Analyze the financial leverage
of Chiome Bioscience Inc compared to its main competitors.

Show all profitability ratios
for Chiome Bioscience Inc.

Provide ROE
for Chiome Bioscience Inc.

Provide ROA
for Chiome Bioscience Inc.

Provide ROIC
for Chiome Bioscience Inc.

Provide ROCE
for Chiome Bioscience Inc.

Provide Gross Margin
for Chiome Bioscience Inc.

Provide Operating Margin
for Chiome Bioscience Inc.

Provide Net Margin
for Chiome Bioscience Inc.

Provide FCF Margin
for Chiome Bioscience Inc.

Show all solvency ratios
for Chiome Bioscience Inc.

Provide D/E Ratio
for Chiome Bioscience Inc.

Provide D/A Ratio
for Chiome Bioscience Inc.

Provide Interest Coverage Ratio
for Chiome Bioscience Inc.

Provide Altman Z-Score Ratio
for Chiome Bioscience Inc.

Provide Quick Ratio
for Chiome Bioscience Inc.

Provide Current Ratio
for Chiome Bioscience Inc.

Provide Cash Ratio
for Chiome Bioscience Inc.

What is the historical Revenue growth
over the last 5 years for Chiome Bioscience Inc?

What is the historical Net Income growth
over the last 5 years for Chiome Bioscience Inc?

What is the current Free Cash Flow
of Chiome Bioscience Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chiome Bioscience Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chiome Bioscience Inc

Current Assets 1.6B
Cash & Short-Term Investments 1.2B
Receivables 92.9m
Other Current Assets 225.1m
Non-Current Assets 134.7m
PP&E 286k
Other Non-Current Assets 134.4m
Current Liabilities 423.2m
Accounts Payable 32.6m
Accrued Liabilities 18.1m
Short-Term Debt 303m
Other Current Liabilities 69.5m
Non-Current Liabilities 55m
Other Non-Current Liabilities 55m
Efficiency

Earnings Waterfall
Chiome Bioscience Inc

Revenue
581.1m JPY
Cost of Revenue
-269.9m JPY
Gross Profit
311.2m JPY
Operating Expenses
-1.5B JPY
Operating Income
-1.2B JPY
Other Expenses
3.8m JPY
Net Income
-1.2B JPY

Free Cash Flow Analysis
Chiome Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Chiome Bioscience Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROE
17/100
Profitability
Score

Chiome Bioscience Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Chiome Bioscience Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
72/100
Solvency
Score

Chiome Bioscience Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Chiome Bioscience Inc

There are no price targets for Chiome Bioscience Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Chiome Bioscience Inc?

Click here to dive deeper.

Dividends

Chiome Bioscience Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Chiome Bioscience Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Chiome Bioscience Inc

Country

Japan

Industry

Life Sciences Tools & Services

Market Cap

11B JPY

Dividend Yield

0%

Description

Chiome Bioscience, Inc. engages in the development and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) system. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 37 full-time employees. The company went IPO on 2011-12-20. The firm operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.

Contact

TOKYO-TO
Shibuya-Ku
12F, Sumitomo Fudosan Nishi-shinjuku Bldg. No.6, 3-12-1, Hon-machi
+81363833561.0
www.chiome.co.jp

IPO

2011-12-20

Employees

37

Officers

CEO, President & Executive Director
Mr. Shigeru Kobayashi M.E.
CFO, Head of Corporate Planning Officer & Executive Director
Mr. Arihiko Bijohira
Head of Business Development and Executive Officer
Mr. Ryuji Osawa Ph.D.
GM of Development Division & Director
Ms. Teruyo Taoka M.B.A., M.S.
Head of Research Division & Executive Director
Dr. Masamichi Koike Ph.D.

See Also

Discover More
What is the Intrinsic Value of one Chiome Bioscience Inc stock?

The intrinsic value of one Chiome Bioscience Inc stock under the Base Case scenario is 26.71 JPY.

Is Chiome Bioscience Inc stock undervalued or overvalued?

Compared to the current market price of 180 JPY, Chiome Bioscience Inc is Overvalued by 85%.

Back to Top